Pharma Stock Roundup: AZN Gets Approvals for Imfinzi Expanded Use, MRK Inks New Deal
Merck (MRK) signs a new collaboration with a private drugmaker. AstraZeneca (AZN) gets approvals for expanded use of Imfinzi.…
£68,063
-50,07%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise?
AstraZenecas (AZN) key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga should drive sales. Its pipeline is huge, with several…
GOLDMAN SACHS stuft ASTRAZENECA auf Buy
NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca nach veröffentlichten Fachartikeln für die anstehende…
Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso
…
AstraZeneca’s Market Cap Soars Past £200 Billion for First Time
AstraZeneca Plc has become the first British company to be valued at more than £200 billion ($257 billion) after a…